Key result
Screening of 150 pregnant women from endemic regions in Mexico City revealed that 20.0% tested positive for T. cruzi infection by at least one diagnostic test, though results varied widely by assay.
Why the study?
Pregnant women and their children are of particular importance to screen because Trypanosoma cruzi can be vertically transmitted, enabling rapid connection to Chagas disease treatment.
Cross-Sectional (n=150)
No
Screening pregnant women from endemic regions in Mexico revealed a 20% positivity rate for T. cruzi by at least one test, highlighting the need for improved diagnostic algorithms to prevent vertical transmission of Chagas disease.
May inform targeted Chagas screening in endemic pregnancies; leaves open standardization of assays before clinical use.
Trypanosoma cruzi infection leads to Chagas disease (CD), a neglected tropical infection of significant public health importance in South and Central America and other, non-endemic, countries. Pregnant women and their children are of particular importance to screen as T. cruzi can be transmitted vertically. The objective of this study was to screen for T. cruzi infection among pregnant women from endemic areas seen at the Hospital General de Mexico for prenatal care, so that they and their children may be quickly connected to CD treatment. Pregnant women were recruited through the hospital prenatal clinic and screened for T. cruzi infection using a series of serological and molecular tests. Of 150 screened patients, mean age 26.8 (SD 6.4), 30 (20.0%) were positive by at least one diagnostic test. Of these, only nine (6%) were positive as determined by PCR. Diagnosis of chronic CD is difficult in endemic places like Mexico due to the limitations of current commercially available diagnostic tests. Further evaluation of diagnostic performance of various assays could improve current CD diagnostic algorithms and proper care management in these regions. Genetic variability in the parasite may also play a role in the differing assay performances seen in this study, and this may be a valuable avenue of further research.
No takes yet. Share an insight, caveat, or question.
Chakravarti et al. (2022) conducted a cross-sectional in Chagas disease (T. cruzi infection) (n=150). T. cruzi infection screening was evaluated on Positive for T. cruzi infection by at least one diagnostic test. Screening of 150 pregnant women from endemic regions in Mexico City revealed that 20.0% tested positive for T. cruzi infection by at least one diagnostic test, though results varied widely by assay.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: